Gastritis induced by Helicobacter pylori infection in experimental rats
- PMID: 20094782
- DOI: 10.1007/s10620-009-1103-y
Gastritis induced by Helicobacter pylori infection in experimental rats
Abstract
Background: Gastritis, an inflammation of gastric mucosa, may be due to many pathological factors and infection, such as with Helicobacter pylori. The use of experimental models of gastritis is important to evaluate the biochemical changes and study chemotherapeutic intervention. In a previous study we demonstrated an acute gastritis model induced by iodoacetamide.
Aims: Our objective in this study was to evaluate a new gastritis model induced by H. pylori infection in experimental rats in terms of certain biomarkers in serum and mucosal tissues in addition to histopathological examination.
Methods: Gastritis was induced in 20 albino Wistar rats by H. pylori isolated from antral biopsy taken from a 49-year-old male patient endoscopically diagnosed as having H. pylori infection. Another ten rats were used as controls. Serum gastrin, pepsinogen I activity, interleukin-6 (IL-6) and gastric mucosal myeloperoxidase (MPO) activity and prostaglandin E(2) (PGE(2)) were measured. Immunostaining for inducible nitric oxide synthase (iNOS), nitrotyrosine and DNA fragmentation were used to further evaluate H. pylori-induced gastritis.
Results: Serum gastrin, IL-6, mucosal MPO activity, and PGE(2) demonstrated significant increases joined with a decreased serum pepsinogen I activity (P < 0.001). Immunohistochemistry demonstrated positive reaction for iNOS, nitrotyrosine and DNA fragmentation.
Conclusions: Helicobacter pylori-induced gastritis models demonstrated massive oxidative stress and pronounced injury in mucosal tissue. Since our model in rats reflected the clinical picture of H. pylori infection, it can be considered as a consistent model to study chemotherapeutic intervention for this type of gastritis.
Similar articles
-
Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori.J Clin Pathol. 2006 Dec;59(12):1293-9. doi: 10.1136/jcp.2005.036111. Epub 2006 Apr 27. J Clin Pathol. 2006. PMID: 16644877 Free PMC article.
-
Helicobacter pylori infection in the cat: evaluation of gastric colonization, inflammation and function.Helicobacter. 2001 Mar;6(1):1-14. doi: 10.1046/j.1523-5378.2001.00010.x. Helicobacter. 2001. PMID: 11328360
-
Changes in the histology and function of gastric mucosa and in Helicobacter pylori colonization during a long-term follow-up period after vagotomy in duodenal ulcer patients.Hepatogastroenterology. 2005 May-Jun;52(63):785-91. Hepatogastroenterology. 2005. PMID: 15966205
-
Helicobacter pylori and acid secretion: where are we now?Eur J Gastroenterol Hepatol. 1997 Apr;9(4):333-5. doi: 10.1097/00042737-199704000-00004. Eur J Gastroenterol Hepatol. 1997. PMID: 9160194 Review.
-
Update in Molecular Aspects and Diagnosis of Autoimmune Gastritis.Curr Issues Mol Biol. 2023 Jun 21;45(7):5263-5275. doi: 10.3390/cimb45070334. Curr Issues Mol Biol. 2023. PMID: 37504250 Free PMC article. Review.
Cited by
-
Integrated analysis of myeloperoxidase in gastric health and cancer: associations with pepsinogen levels, immune regulation, and prognosis in a large healthy population-based and TCGA cohorts.Front Immunol. 2025 Jun 6;16:1590257. doi: 10.3389/fimmu.2025.1590257. eCollection 2025. Front Immunol. 2025. PMID: 40547041 Free PMC article.
-
A novel cycloastragenol-encapsulated carboxymethyl chitosan-silk fibroin hydrogel combined with sucralfate alleviates MNNG-induced chronic atrophic gastritis by targeting HIF-1α and VEGF signaling pathways.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 9. doi: 10.1007/s00210-025-04242-4. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40488849
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous